These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18473691)

  • 1. How would patients behave if they were continually informed of their blood glucose levels? A simulation study using a "virtual" patient.
    Biermann E; Barkhausen K; Standl E
    Diabetes Technol Ther; 2008 Jun; 10(3):178-87. PubMed ID: 18473691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulation and qualitative analysis of glucose variability, mean glucose, and hypoglycemia after subcutaneous insulin therapy for stress hyperglycemia.
    Strilka RJ; Stull MC; Clemens MS; McCaver SC; Armen SB
    Theor Biol Med Model; 2016 Jan; 13():3. PubMed ID: 26819233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of number and duration of hypoglycemic events by glucose prediction methods: a proof-of-concept in silico study.
    Zecchin C; Facchinetti A; Sparacino G; Cobelli C
    Diabetes Technol Ther; 2013 Jan; 15(1):66-77. PubMed ID: 23297671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support.
    Dickerson RN; Hamilton LA; Connor KA; Maish GO; Croce MA; Minard G; Brown RO
    Nutrition; 2011; 27(7-8):766-72. PubMed ID: 20971617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of measurement frequency on the domains of glycemic control in the critically ill--a Monte Carlo simulation.
    Krinsley JS; Bruns DE; Boyd JC
    J Diabetes Sci Technol; 2015 Mar; 9(2):237-45. PubMed ID: 25568143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
    Peyrot M; Rubin RR
    Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAR development and protocol comparison.
    Fisk LM; Le Compte AJ; Shaw GM; Penning S; Desaive T; Chase JG
    IEEE Trans Biomed Eng; 2012 Dec; 59(12):3357-64. PubMed ID: 22929365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous glucose monitors and the burden of tight glycemic control in critical care: can they cure the time cost?
    Signal M; Pretty CG; Chase JG; Le Compte A; Shaw GM
    J Diabetes Sci Technol; 2010 May; 4(3):625-35. PubMed ID: 20513329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delay in blood glucose monitoring during an insulin infusion protocol is associated with increased risk of hypoglycemia in intensive care units.
    Garg R; Jarry A; Pendergrass M
    J Hosp Med; 2009 Jul; 4(6):E5-7. PubMed ID: 19670374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitional NPH insulin therapy for critically ill patients receiving continuous enteral nutrition and intravenous regular human insulin.
    Dickerson RN; Wilson VC; Maish GO; Croce MA; Minard G; Brown RO
    JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):506-16. PubMed ID: 22914894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter evaluation of blood glucose awareness training-II.
    Cox D; Gonder-Frederick L; Polonsky W; Schlundt D; Julian D; Clarke W
    Diabetes Care; 1995 Apr; 18(4):523-8. PubMed ID: 7497863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypo- and hyperglycemia in relation to the mean, standard deviation, coefficient of variation, and nature of the glucose distribution.
    Rodbard D
    Diabetes Technol Ther; 2012 Oct; 14(10):868-76. PubMed ID: 22953755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe and effective use of a glycemic control protocol for neonates in a cardiac ICU.
    Hebson CL; Chanani NK; Rigby MR; Wolf MJ; Deshpande SR; Montegna LM; Maher KO
    Pediatr Crit Care Med; 2013 Mar; 14(3):284-9. PubMed ID: 23392366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin therapy by insulin pump: continuous or conventional self-blood glucose monitoring? ].
    Renard E
    Diabetes Metab; 2003 Apr; 29(2 Pt 2):S54-62. PubMed ID: 12746628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial.
    Tanenberg R; Bode B; Lane W; Levetan C; Mestman J; Harmel AP; Tobian J; Gross T; Mastrototaro J
    Mayo Clin Proc; 2004 Dec; 79(12):1521-6. PubMed ID: 15595336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Glucose Monitoring Measures Can Be Used for Glycemic Control in the ICU: An In-Silico Study.
    Zhou T; Dickson JL; Shaw GM; Chase JG
    J Diabetes Sci Technol; 2018 Jan; 12(1):7-19. PubMed ID: 29103302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved safety with intravenous insulin therapy for critically ill patients with renal failure.
    Dickerson RN; Lynch AM; Maish GO; Croce MA; Minard G; Brown RO
    Nutrition; 2014 May; 30(5):557-62. PubMed ID: 24296035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inpatient glucose control: a glycemic survey of 126 U.S. hospitals.
    Cook CB; Kongable GL; Potter DJ; Abad VJ; Leija DE; Anderson M
    J Hosp Med; 2009 Nov; 4(9):E7-E14. PubMed ID: 20013863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous intra-arterial blood glucose monitoring using quenched fluorescence sensing in intensive care patients after cardiac surgery: phase II of a product development study.
    Macken L; Flower OJ; Bird S; Hammond N; Yarad E; Bass F; Fisher C; Strasma P; Finfer S
    Crit Care Resusc; 2015 Sep; 17(3):190-6. PubMed ID: 26282257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.